Overweight, insulin resistant women at greater risk of advanced breast cancer diagnosis, says studyJuly 08, 2008Women who have risk factors commonly associated with type 2 diabetes also have much greater odds of being diagnosed with an advanced breast cancer, according to research to be presented today Women who have risk factors commonly associated with Type 2 diabetes also have much greater odds of being diagnosed with an advanced breast cancer, according to research to be presented today (Tuesday 8 July 2008). University of Melbourne researcher Dr Anne Cust was a key collaborator on an international study which will today be presented to the Population Health 2008 Conference in Brisbane. The study found that women who were overweight or had signs of insulin resistance - such as elevated blood glucose or insulin levels - were about 50 per cent more likely to be diagnosed with an advanced breast cancer tumor. Researchers tracked more than 60,000 Swedish women over a 20-year-period from 1985 to 2005. All were cancer free when recruited and their blood tested for glucose, insulin and other hormones associated with obesity and diabetes risk. Insulin resistance is most commonly caused by being overweight and inactive and is often a precursor to Type 2 diabetes. Dr Cust said that previous research had shown a strong link between being overweight and increased breast cancer risk in post menopausal women- but this study was the first to demonstrate the influence of insulin resistance on the stage of cancer diagnosis. "Women with insulin resistance or who were overweight were less likely to be diagnosed with stage 1 breast cancers but at greater risk of being diagnosed with stage 2 to 4 tumors - larger more advanced cancers,'' she said. "We know that being overweight and having insulin resistance is a risk factor for getting cancer but - in the case of breast cancer - our study indicates that the cancer will be more advanced." Dr Cust said the research findings were particularly significant at a time when there were major public health concerns about obesity and Type 2 diabetes rates. University of Melbourne |
|||||||||||||||||||||
| Related Breast Cancer Current Events and Breast Cancer News Articles Menopause-cardiology consensus statement on cardiovascular disease and on HRT A menopause-cardiology consensus statement has called for direct action to prevent cardiovascular disease (CVD) in menopausal women. The statement also concludes that there is little evidence of increased CVD risk in taking HRT. Researchers Identify Role of Gene in Tumor Development, Growth and Progression Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine researchers have identified a gene that may play a pivotal role in two processes that are essential for tumor development, growth and progression to metastasis. UCLA researchers create 'fly paper' to capture circulating cancer cells Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor. Fertility procedures need not delay breast cancer treatment for younger women A new study published in the November issue of the Journal of the American College of Surgeons shows that breast cancer patients under 40 years old who undergo fertility preservation do not face a significant delay in the treatment of their disease when their care is coordinated in a timely fashion. Coffee break: Compound brewing new research in colon, breast cancer A compound in coffee has been found to be estrogenic in studies by Texas AgriLife Research scientists. Drugs to treat anemia in cancer patients linked to thromboembolism Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, according to new research led by Dawn Hershman, M.D, M.S., co-director of the breast cancer program at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center. Discovery in worms by Queen's researchers points to more targeted cancer treatment Researchers at Queen's University have found a link between two genes involved in cancer formation in humans, by examining the genes in worms. The groundbreaking discovery provides a foundation for how tumor-forming genes interact, and may offer a drug target for cancer treatment. FDA approved leukemia drugs shows promise in ovarian cancer cells The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a study by researchers with UCLA's Jonsson Comprehensive Cancer Center found. Carnegie Mellon researchers link health-care debate to risk of dying in US and Europe The current health care debate in the United States is complicated. Trade-offs between heath care expenditures, lifestyle choices and life expectancy have been suggested but seldom clearly demonstrated. Scientists uncover new key to the puzzle of hormone therapy and breast cancer The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer. More Breast Cancer Current Events and Breast Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||